Search references for FULZERASIB. Phrases containing FULZERASIB
See searches and references containing FULZERASIB!FULZERASIB
Pharmaceutical compound
Fulzerasib is a drug that is approved in China to treat KRAS G12C-positive non-small cell lung cancer (NSCLC). Prior to marketing approval, fulzerasib
Fulzerasib
Protein-coding gene in humans
mutation in patients who have received at least one systemic treatment. Fulzerasib has also been approved for the same indication in China. The most common
KRAS
travel, tourism, insurance
FULZERASIB
FULZERASIB
FULZERASIB
FULZERASIB
FULZERASIB
FULZERASIB
FULZERASIB
FULZERASIB
FULZERASIB
travel, tourism, insurance